Impax Labs announced the July 30, 2004 approval of an Abbreviated New Drug Application (ANDA 076249) from the FDA, marking a significant milestone for...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
SpecGx LLC announced FDA approval of the 40 mg and 80 mg strengths of the generic version of Oxycontin (oxycodone hydrochloride) on Tuesday. The avail...
SpecGx LLC received FDA approval for a generic version of the combination pain reliever oxycodone hydrochloride and acetaminophen, offering the agency...
On June 16, 2004, ACTAVIS LABS FL INC received FDA approval for ANDA076172, allowing the company to launch a generic drug without a specific brand or ...
The U.S. Food and Drug Administration has approved a generic drug application from Apotex, marking a potential new entrant into the market and driving...
The FDA approved Actavis Pharma, Inc.'s application for the generic oral version of Fioricet With Codeine (butalbital, acetaminophen, caffeine, and co...
IVAX SUB TEVA PHARMS received FDA approval for ANDA076089 on June 9, 2004, paving the way for the launch of a new generic drug that barring patent cha...
HIKMA announced that the FDA has approved its ANDA 076558 on June 9, 2004, yet the file lacks specified brand, generic, and substance details required...
Amneal Pharmaceuticals received FDA approval to manufacture the generic version of brand-name CARBIDOPA AND LEVODOPA formulations, providing additiona...
SpecGx LLC received FDA approval on April 27, 2004, for its Abbreviated New Drug Application (ANDA040517) for OROXTM METHADONE HYDROCHLORIDE, potentia...
# FDA Approves Eli Lilly's ZYPREXA Intramuscular Formulation Eli Lilly and Company received FDA approval for ZYPREXA (olanzapine) intramuscular injec...
Kenvue Brands LLC has confirmed the continued availability of ZYRTEC (cetirizine hydrochloride), a global allergy leader initially approved by the FDA...
On February 27, 2004, the FDA approved the oral version of Novartis Pharmaceuticals Corporation's immunosuppressant Myfortic (mycophenolic acid), allo...
IMPAX Pharmaceuticals received FDA approval on February 18, 2004, for NDA ANDA076345, marking a pivotal entry into the generic pharmaceutical market w...
Actavis Elizabeth received final FDA approval on February 6, 2004, for the generic drug referenced in ANDA076636; the filing is expected to trigger ma...
Actavis Labs FL Inc. secured FDA approval for its generic product, bolstering its financial outlook by expanding its portfolio in a highly competitive...
The FDA has granted approval to Chartwell Governmental & Specialty RX, LLC for the generic version of ETHOSUXIMIDE, which is poised to intensify marke...
Watson Labs received an FDA approval that is expected to enhance revenue growth as the company prepares to launch a new generic product. This approval...
Sandoz Inc. announced the launch of generic digoxin injection in follow-on to an August 21, 2003, FDA approval, following a standard ANDA filing. Mark...
# FDA Approves AstraZeneca's CRESTOR (rosuvastatin calcium) for Cholesterol Management AstraZeneca Pharmaceuticals LP has received FDA approval for C...